Frankfurt - Delayed Quote EUR
Solasia Pharma K.K. (9SO.F)
0.1690
+0.0010
+(0.60%)
As of 8:02:09 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-1,033,000
-1,033,000
-359,000
-2,074,000
-2,473,000
Investing Cash Flow
0
0
0
-418,000
-164,000
Financing Cash Flow
1,180,000
1,180,000
275,000
2,571,000
361,000
End Cash Position
886,000
886,000
728,000
803,000
714,000
Capital Expenditure
-1,000
-1,000
--
-403,000
-163,000
Issuance of Capital Stock
1,215,000
1,215,000
318,000
2,611,000
1,403,000
Issuance of Debt
500,000
500,000
0
500,000
0
Repayment of Debt
-500,000
-500,000
0
-500,000
-1,000,000
Repurchase of Capital Stock
--
--
--
0
0
Free Cash Flow
-1,034,000
-1,034,000
-359,000
-2,477,000
-2,636,000
12/31/2021 - 4/6/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6QC.F Towa Pharmaceutical Co., Ltd.
15.40
-1.91%
1MRK.MI Merck KGaA
124.35
-1.27%
3D7.F Willow Biosciences Inc.
0.0160
-15.79%
CAIHF Chia Tai Enterprises International Limited
0.0100
0.00%
2WU.F Lowell Farms Inc. R
0.0005
0.00%
0T01.F TILT Holdings Inc.
0.0050
0.00%
8Z1.F PharmaEssentia Corporation
0.0000
-100.00%
4KF0.F Glass House Brands Inc.
3.7200
+3.91%
AVCNF Avicanna Inc.
0.1730
0.00%
BSPK Bespoke Extracts, Inc.
0.1023
0.00%